查詢結果分析
來源資料
相關文獻
- 全自動雙重過濾血漿置換術之臨床經驗
- 照顧一位罹患Guillian-Barre症候群病患之護理經驗
- 血漿置換術在狼瘡腎炎之臨床應用
- The Kinetics of Plasma Constituents Change in Cascade Filtration Plasmapheresis
- Guillain-Barre'症候群的治療原則
- 危急中毒病患的救星--體外排毒方法
- Complications of Membrane-Filtration Plasma Exchange
- Hemolysis in Plasmapheresis
- 概觀血液透析之血管通路
- Hemolytic-Uremic Syndrome Following Excessive Heroin Inhalation
頁籤選單縮合
題 名 | 全自動雙重過濾血漿置換術之臨床經驗=Clinical Experience of Automated Double Filtration Plasmapheresis |
---|---|
作 者 | 李建德; 莊峰榮; 許國泰; 林景坤; 廖上智; 劉勁初; 陳靖博; 張世偉; 簡玉樹; 潘咸亨; | 書刊名 | 長庚醫學 |
卷 期 | 19:4 1996.12[民85.12] |
頁 次 | 頁313-319 |
分類號 | 415.74 |
關鍵詞 | 血漿置換術; 雙重過濾血漿置換術; Plasmapheresis; Double filtration plasmapheresis; |
語 文 | 中文(Chinese) |
中文摘要 | 背景:血漿置換術在臨床上的應用已有數十年的歷史,在技術的改良上更由膜式血漿分離發展出雙重過濾血漿置換術,利用分子量大小不同做有選擇性的分離。本院於1993年12月首次引進該種機器從事臨床治療。針對此一新技術,我們報告其使用之經驗。 方法:在一年間共有13位病人接受共一百次治療。治療對象包括8位重症肌無力患者,其他急性發炎性去髓鞘多發性神經病變、多發性骨髓癌、後天性第八凝血因子抑制素、自體免疫性貧血及系統性紅斑狼瘡各1位。 結果:治療效果以重症肌無力、急性發炎性去髓鞘多發性神經病變及後天性第八凝血因子抑制素較佳。併發症極少只有低血壓2次(2%)心悸1次(1%)頭痛1次(1%)肉眼可見溶血4次(4%)空氣栓塞1次(1%)二次膜壓高2次(2%)。此外並無死亡病例。 結論:我們認為全自動雙重過濾血漿置換術是一種省時、方便、易操作,無須大量補充液,而且併發症少安全性安全性高的新治療方式。在慎選病例積極治療下,某些特定疾病具相當顯著的療效而值得採用。 |
英文摘要 | Double filtration plasmaphersis, one kind of fractionation plasmapheresis, was developed from membrane type plasmapheresis to remove only the pathogen and return the normal protein back to the patient. We started our automated double filtration plasmapheresis since Decembet 1993. There were 13 patients who received one hundred treatments totally during one year period. And they are myasthenia gravis (8 patients); acute inflammatory demyelinating polyneuropathy (1 patient), multiple myeloma (1 patient); acquired factor VII inhibitor (1 patient); autoimmune hemolytic anemia (1 patient); systemic lupus erythematous (1 patient). Technically double filtration plasmapheresis is easy to perform and time-saving. It also makes necessity of replacement fluid less frequent. Incidence of complication is rare, and this includes hypotension 2%, palpitation 1%, headache 1%, hemolysis 4%, air emboli 1%, high secondary pressure 2%, and no motality during our treatment. Clinical response is documented in cased of myasthenia gravis; acute inflammatory demyelinating polyneuropathy and acquried factor VIII inhibitor in our study. In conclusion, double filtration plasmapheresis is a time-saving, convenient, and safe therapeutic modality with rare complication. Because its effectiveness on limited kinds of diseases and treat aggressively if indicated. |
本系統中英文摘要資訊取自各篇刊載內容。